ARCHIVES

Cancer Groups Criticize Prescription Drug Bills.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

Pinkel Corrects Report On ALL – Two Drugs Are Better Than One

April 21, 1978

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

DRCCA Board Okays Four Concepts, Rejects One, Tables Two Others

May 27, 1983